Global Insulin Biosimilars Market Size, Share, Growth Analysis, By Type(Fast-acting Insulin, Intermediate-acting Insulin), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies), By Indication(Diabetes Type 1, and Diabetes Type 2) - Industry Forecast 2024-2031

Global Insulin Biosimilars Market size was valued at USD 2.67 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 4.07 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).

全球胰岛素生物类似物市场规模于2022年达到了26.7亿美元的估值，预计将从2023年的28亿美元增长至2031年的40.7亿美元，在预测期内（2024-2031年）的复合年增长率将达到4.8%。